These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

376 related articles for article (PubMed ID: 33694050)

  • 1. Prognostic models for amyotrophic lateral sclerosis: a systematic review.
    Xu L; He B; Zhang Y; Chen L; Fan D; Zhan S; Wang S
    J Neurol; 2021 Sep; 268(9):3361-3370. PubMed ID: 33694050
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Development of a prognostic model of respiratory insufficiency or death in amyotrophic lateral sclerosis.
    Ackrivo J; Hansen-Flaschen J; Wileyto EP; Schwab RJ; Elman L; Kawut SM
    Eur Respir J; 2019 Apr; 53(4):. PubMed ID: 30728207
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Model-Based and Model-Free Techniques for Amyotrophic Lateral Sclerosis Diagnostic Prediction and Patient Clustering.
    Tang M; Gao C; Goutman SA; Kalinin A; Mukherjee B; Guan Y; Dinov ID
    Neuroinformatics; 2019 Jul; 17(3):407-421. PubMed ID: 30460455
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Mechanical ventilation for amyotrophic lateral sclerosis/motor neuron disease.
    Radunovic A; Annane D; Rafiq MK; Mustfa N
    Cochrane Database Syst Rev; 2013 Mar; (3):CD004427. PubMed ID: 23543531
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Creatine for amyotrophic lateral sclerosis/motor neuron disease.
    Pastula DM; Moore DH; Bedlack RS
    Cochrane Database Syst Rev; 2010 Jun; (6):CD005225. PubMed ID: 20556761
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prognosis for patients with amyotrophic lateral sclerosis: development and validation of a personalised prediction model.
    Westeneng HJ; Debray TPA; Visser AE; van Eijk RPA; Rooney JPK; Calvo A; Martin S; McDermott CJ; Thompson AG; Pinto S; Kobeleva X; Rosenbohm A; Stubendorff B; Sommer H; Middelkoop BM; Dekker AM; van Vugt JJFA; van Rheenen W; Vajda A; Heverin M; Kazoka M; Hollinger H; Gromicho M; Körner S; Ringer TM; Rödiger A; Gunkel A; Shaw CE; Bredenoord AL; van Es MA; Corcia P; Couratier P; Weber M; Grosskreutz J; Ludolph AC; Petri S; de Carvalho M; Van Damme P; Talbot K; Turner MR; Shaw PJ; Al-Chalabi A; Chiò A; Hardiman O; Moons KGM; Veldink JH; van den Berg LH
    Lancet Neurol; 2018 May; 17(5):423-433. PubMed ID: 29598923
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The prognostic value of spirometric tests in Amyotrophic Lateral Sclerosis patients.
    Pirola A; De Mattia E; Lizio A; Sannicolò G; Carraro E; Rao F; Sansone V; Lunetta C
    Clin Neurol Neurosurg; 2019 Sep; 184():105456. PubMed ID: 31382080
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prognostic factors for the course of functional status of patients with ALS: a systematic review.
    Creemers H; Grupstra H; Nollet F; van den Berg LH; Beelen A
    J Neurol; 2015 Jun; 262(6):1407-23. PubMed ID: 25385051
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Repetitive transcranial magnetic stimulation for the treatment of amyotrophic lateral sclerosis or motor neuron disease.
    Guo J; Zhou M; Yang M; Zhu C; He L
    Cochrane Database Syst Rev; 2011 Sep; (9):CD008554. PubMed ID: 21901724
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Aberrant Levels of Cystatin C in Amyotrophic Lateral Sclerosis: a Systematic Review and Meta Analysis.
    Zhu Y; Yang M; Li F; Li M; Xu Z; Yang F; Liu Y; Chen W; Zhang Y; Xu R
    Int J Biol Sci; 2018; 14(9):1041-1053. PubMed ID: 29989057
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Artificial intelligence and statistical methods for stratification and prediction of progression in amyotrophic lateral sclerosis: A systematic review.
    Tavazzi E; Longato E; Vettoretti M; Aidos H; Trescato I; Roversi C; Martins AS; Castanho EN; Branco R; Soares DF; Guazzo A; Birolo G; Pala D; Bosoni P; Chiò A; Manera U; de Carvalho M; Miranda B; Gromicho M; Alves I; Bellazzi R; Dagliati A; Fariselli P; Madeira SC; Di Camillo B
    Artif Intell Med; 2023 Aug; 142():102588. PubMed ID: 37316101
    [TBL] [Abstract][Full Text] [Related]  

  • 12. C-reactive protein levels in patients with amyotrophic lateral sclerosis: A systematic review.
    Kharel S; Ojha R; Preethish-Kumar V; Bhagat R
    Brain Behav; 2022 Mar; 12(3):e2532. PubMed ID: 35201675
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Biological follow-up in amyotrophic lateral sclerosis: decrease in creatinine levels and increase in ferritin levels predict poor prognosis.
    Patin F; Corcia P; Madji Hounoum B; Veyrat-Durebex C; Respaud E; Piver E; Benz-de Bretagne I; Vourc'h P; Andres CR; Blasco H
    Eur J Neurol; 2015 Oct; 22(10):1385-90. PubMed ID: 26095828
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Using an onset-anchored Bayesian hierarchical model to improve predictions for amyotrophic lateral sclerosis disease progression.
    Karanevich AG; Statland JM; Gajewski BJ; He J
    BMC Med Res Methodol; 2018 Feb; 18(1):19. PubMed ID: 29409450
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Developing a novel immune infiltration-associated mitophagy prediction model for amyotrophic lateral sclerosis using bioinformatics strategies.
    Du R; Chen P; Li M; Zhu Y; He Z; Huang X
    Front Immunol; 2024; 15():1360527. PubMed ID: 38601155
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mechanical ventilation for amyotrophic lateral sclerosis/motor neuron disease.
    Radunovic A; Annane D; Jewitt K; Mustfa N
    Cochrane Database Syst Rev; 2009 Oct; (4):CD004427. PubMed ID: 19821325
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Rate of disease progression: a prognostic biomarker in ALS.
    Labra J; Menon P; Byth K; Morrison S; Vucic S
    J Neurol Neurosurg Psychiatry; 2016 Jun; 87(6):628-32. PubMed ID: 26152368
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Systematic Review and Meta-Analyses of Aminopeptidases as Prognostic Biomarkers in Amyotrophic Lateral Sclerosis.
    Teruel-Peña B; Gómez-Urquiza JL; Suleiman-Martos N; Prieto I; García-Cózar FJ; Ramírez-Sánchez M; Fernández-Martos C; Domínguez-Vías G
    Int J Mol Sci; 2023 Apr; 24(8):. PubMed ID: 37108335
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects of cannabinoids in Amyotrophic Lateral Sclerosis (ALS) murine models: a systematic review and meta-analysis.
    Urbi B; Owusu MA; Hughes I; Katz M; Broadley S; Sabet A
    J Neurochem; 2019 Apr; 149(2):284-297. PubMed ID: 30520038
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Towards a Machine Learning Empowered Prognostic Model for Predicting Disease Progression for Amyotrophic Lateral Sclerosis.
    Turabieh H; Afshar AS; Statland J; Song X;
    AMIA Annu Symp Proc; 2023; 2023():718-725. PubMed ID: 38222431
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.